While SIRT1 decreases with increasing body fat [9], sclerostin expression increases in parallel with adipose tissue [23] and insulin resistance [46], and promotes adipocyte hypertrophy [19,47] and the differentiation of bone precursors into white adipocytes, reducing bone formation. This evidence concerns the gene SOST and Insulin resistance.